Enzymology in Drug Discovery

Enzymes are the proteins in the drug design that act as drug targets for the diseases in the process of drug discovery and development. There are number of drug targets involved in the designing of the drug.

Drug target as a nucleic acid or a protein (e.g. an enzyme, a receptor) whose activity can be modified by a drug. The drug can be a small-molecular-weight chemical compound or a biological, such as an antibody or a recombinant protein. The drug target should have been shown to be effective/mechanistically involved in the disease by relevant in vitro or in vivo models.

  • Drug designing using enzymes
  • Drug development using enzymes
  • Drug modelling
  • Drug targeting

Related Conference of Enzymology in Drug Discovery

April 16-17, 2020

16th World Congress on Structural Biology

Amsterdam, Netherlands
April 20-21, 2020

11th Tissue Science and Regeneration Congress

Kuala Lumpur, Malaysia
June 28-30 2020

globalbiotechnology-cs-2020

June 28-30 2020

oilgas-cs-2020

June 28-30 2020

BEHAVIOURAL SCIENCE-2020

June 28-30 2020

Bioinfo 2020

July 17-18, 2020

10th Glycobiology World Congress

Vienna, Austria
August 04,05 2020

12th Euro Biosensors & Bioelectronics Congress

Zurich, Switzerland
June 28-30 2020

NURSE PRACTITIONER 2020

September 28-29, 2020

19th International Conference on Structural Biology

Barcelona, Spain
October 14-15, 2020

9th World Congress on Glycobiology & Glycochemistry

Rome, Italy
December 10-11, 2020

2nd European Pathology and Infectious Disease Conference

Abu Dhabi, UAE

Enzymology in Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in